MedCity News May 9, 2021
Elise Reuter

Mayo Clinic shared results of a study showing that an AI tool developed by the system could be used to improve diagnosis of low ejection fraction, a type of heart disease. It’s part of a broader push by Mayo Clinic to commercialize AI-based diagnostic tools, starting with spinout company Anumana.

After spinning up a pair of companies to commercialize remote diagnostic tools, Mayo Clinic shared the results of a study indicating an AI algorithm could be used to improve diagnosis of a certain type of heart disease.

The algorithm, which was developed internally at Mayo Clinic using a type of neural network, was designed to screen for low ejection fraction, a condition where the heart can’t contract strongly enough to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Provider, Technology
5 tips on AI adoption from a frontline physician champion
US federal agencies must have a chief AI officer under new order
AI expertise gets more expensive as hospitals bulk up
Prompt Engineering For Healthcare: 11 Tips To Craft Great ChatGPT Prompts - March 2024
AI nurses? Inside Nvidia, Hippocratic AI's new partnership

Share This Article